Appropriate
selection of excipients during the new product development is one of
the critical in the pharmaceutical formulations. Criteria for
selection of suitable excipient depend on the physical, chemical and
biological properties of the excipient. Primarily, it should help
stabilize and protect the drug/active pharmaceutical ingredient (API)
in the formulation against degradation, oxidation or aggregation,
during manufacturing, transport and storage.
Browse
Albumin Market Report with Full TOC at
http://www.transparencymarketresearch.com/albumin-market.html
Preformulation
studies comprise investigation of drug-excipient interactions that
help in selection of appropriate excipients to achieve the desired
properties for the final drug product. Albumin is a well
characterized protein and functions as a therapeutic, diagnostic
agent, as well as an excipient. As an excipient, albumin has wide
applications in drug formulation, drug delivery, vaccine
manufacturing and as a component of media in vaccine production.
Stable nature of albumin makes its handling and storage easier than
other proteins, making it suitable for use as an excipient. Albumin
due to its intrinsic stability can be heated at 60°C for 10 hours
facilitating virus inactivation during manufacturing.
This
report studies the global market for albumin encompassing type,
applications and geography. Types of albumin include human serum
albumin, bovine serum albumin and recombinant albumin. Major
applications for albumin as an excipient comprise drug formulation
and drug delivery, vaccines and component of medium. Each of these
segments has been analyzed in detail from market trends and recent
developments to future outlook and opportunities. The report provides
the albumin market size in terms of value (USD million) and volume
(kg) for each segment and sub-segment for the period from 2012 to
2020, considering the macro- and micro environmental factors. In
addition, the compounded annual growth rate (CAGR) of the overall
albumin market and the segments has also been provided in the report
for the forecast period 2014 to 2020, considering 2012 as historical
year and 2013 as the base year. The global albumin market report also
includes an elaborate executive summary, which covers a market
snapshot representing key findings from the study.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3984
Geographically,
the global albumin market has been segmented into four regions: North
America, Europe, Asia Pacific and Rest of the World (RoW). The market
size and forecast in terms of value (USD million) and volume (kg) for
each of these regions along with the CAGR for the forecast period
from 2014 to 2020 have been provided in the report. A detailed
qualitative analysis of the major factors determining market dynamics
such as drivers, restraints and opportunities, along with the market
attractiveness analysis are discussed in the market overview section
of the report. The study also provides a list of recommendations for
new companies willing to enter the market and for existing companies
to increase market shares, which is likely to help in the
decision-making process. Event impact analysis and clinical pipeline
analysis have also been provided for albumin as an excipient in this
report that will help in understanding the major events impacting the
albumin market growth. Number of clinical trials also demonstrates
the potential of albumin use as an excipient in pharmaceutical
formulations.
The
study is a robust combination of primary and secondary research.
Primary research formed the bulk of our research efforts with
information collected from telephonic interviews and interaction via
e-mails. Secondary research involved study of company websites,
annual reports, press releases, stock analysis presentations, and
various international and national databases for patents, clinical
trials, demographics, disease incidence/prevalence, etc. The key
players operating in the albumin market are CSL Behring LLC, HiMedia
Laboratories Pvt. Ltd., InVitria, MedzBio Pte. Ltd., Mitsubishi
Tanabe Pharma Corporation, Novozymes A/S, Octapharma AG, RayBiotech,
Inc., Sigma-Aldrich Corporation, and Thermo Fisher Scientific.
The
global albumin market is segmented as follows:
Albumin
Market Revenue (USD Million), by Type
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Albumin
Market Revenue (USD Million) and Volume (kg), by Application
- Drug Formulation and Drug Delivery
- Vaccines
- Component of Medium
Albumin
Market Revenue (USD Million) and Volume (kg), by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
Browse
all Pharmaceutical Market Research Report
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.htm
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment